AKT1 and cancer: Taken together, these data suggested that the PI3K/AKT pathway negatively regulates the expression of the E3 ligase TRIM21, which in turn controls the level and activity of the PPP rate-limiting enzyme G6PD via ubiquitin-mediated degradation in vivo and in human cancers.